首页> 外文期刊>Cell >Systemic endocrine instigation of indolent tumor growth requires osteopontin
【24h】

Systemic endocrine instigation of indolent tumor growth requires osteopontin

机译:全身性内分泌刺激性肿瘤生长需要骨桥蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

The effects of primary tumors on the host systemic environment and resulting contributions of the host to tumor growth are poorly understood. Here, we find that human breast carcinomas instigate the growth of otherwise-indolent tumor cells, micrometastases, and human tumor surgical specimens located at distant anatomical sites. This systemic instigation is accompanied by incorporation of bone-marrow cells (BMCs) into the stroma of the distant, once-indolent tumors. We find that BMCs of hosts bearing instigating tumors are functionally activated prior to their mobilization; hence, when coinjected with indolent cells, these activated BMCs mimic the systemic effects imparted by instigating tumors. Secretion of osteopontin by instigating tumors is necessary for BMC activation and the subsequent outgrowth of the distant otherwise-indolent tumors. These results reveal that outgrowth of indolent tumors can be governed on a systemic level by endocrine factors released by certain instigating tumors, and hold important experimental and therapeutic implications.
机译:人们对原发性肿瘤对宿主系统环境的影响以及宿主对肿瘤生长的贡献知之甚少。在这里,我们发现人类乳腺癌会促进原本处于惰性的肿瘤细胞,微转移瘤和位于远处解剖部位的人类肿瘤手术标本的生长。这种全身性的刺激伴随着将骨髓细胞(BMC)掺入到远距的,曾经是惰性的肿瘤的基质中。我们发现携带诱使性肿瘤的宿主的BMC在动员之前已被功能性激活。因此,当与惰性细胞共同注射时,这些活化的BMC会模仿诱发肿瘤所产生的全身作用。通过激活肿瘤来分泌骨桥蛋白对于BMC激活以及随后的远处原本为惰性的肿瘤的生长是必需的。这些结果表明,惰性肿瘤的生长可以由某些诱发性肿瘤释放的内分泌因素在全身水平上进行控制,并具有重要的实验和治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号